What are Rigel Pharmaceuticals's profit margins?

Rigel Pharmaceuticals (RIGL) runs a 93.4% gross margin and a 41.6% operating margin, with a 121.5% net margin.

Where do Rigel Pharmaceuticals's ratios come from?

Every ratio is computed from Rigel Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Rigel Pharmaceuticals RIGL Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Gross margin	93.3%+3.7pp	89.6%-4.3pp	93.9%-4.6pp	98.5%-0.7pp
Operating margin	42.6%+29.1pp	13.5%+32.7pp	-19.2%+28.7pp	-47.9%-39.6pp
Net margin	124.7%+115pp	9.8%+31.9pp	-22.1%+27.8pp	-49.9%-37.9pp
EBITDA margin	43.5%+28.7pp	14.7%+32.9pp	-18.2%+28.9pp	-47.1%-39.5pp
Returns
Return on equity	185.9%—	——	——	——
Return on assets	108.3%+95.9pp	12.4%+33.0pp	-20.5%+19.2pp	-39.8%-26.9pp
Efficiency
Asset turnover	0.9×-0.4×	1.3×+0.3×	0.9×+0.1×	0.8×-0.3×
Inventory turnover	2.2×-1.0×	3.2×+2.3×	1×+0.7×	0.2×0.0×
Liquidity
Current ratio	2.4×+0.3×	2.1×+0.3×	1.9×+0.1×	1.8×-0.7×
Quick ratio	2.3×+0.3×	2×+0.3×	1.8×+0.1×	1.6×-0.7×
Cash ratio	0.4×-0.5×	0.9×+0.3×	0.6×+0.2×	0.4×+0.1×
Leverage
Debt-to-equity	0.2×+0.1×	0.1×—	——	——
Debt-to-assets	0.2×+0.2×	0×0.0×	0×0.0×	0×0.0×
Net debt / EBITDA	0.3×+2.5×	-2.1×—	——	——
Interest coverage	17.1×+14.1×	3.1×+6.3×	-3.3×+12.3×	-15.5×-13.0×
Per Share
Book value per share	$20.78+11,078%	$0.19+111%	-$1.65-106%	-$0.80-548%
Valuation
Market capitalization	$684.39M+102%	$296.28M+17.2%	$252.84M-2.5%	$259.25M-42.8%
Enterprise value	$728.29M+148%	$239.82M+8.5%	$221.03M-6.7%	$236.9M-46.8%
Price / earnings	1.9×-7.2×	16.9×—	——	——
Price / sales	2.3×+0.6×	1.7×-0.5×	2.2×0.0×	2.2×-0.9×
Price / book	1.7×-16.5×	90.1×—	——	——
EV / EBITDA	5.7×-0.6×	9.1×—	——	——
EV / sales	2.4×+1.0×	1.3×-0.6×	1.9×-0.1×	2×-1.0×
Earnings yield	53.2%+42.2pp	5.9%+16.1pp	-10.2%+12.9pp	-23.1%-19.2pp
PEG ratio	0×—	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Rigel Pharmaceuticals.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Rigel Pharmaceuticals's profit margins?: Rigel Pharmaceuticals (RIGL) runs a 93.4% gross margin and a 41.6% operating margin, with a 121.5% net margin.
Where do Rigel Pharmaceuticals's ratios come from?: Every ratio is computed from Rigel Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.